| 0338-9640 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION . VASOPRESSIN IN SODIUM CHLORIDE INJECTION, for intravenous use Initial U.S. Approval: 2014 | Baxter Healthcare Corporation |
| 0338-9640-12 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION . VASOPRESSIN IN SODIUM CHLORIDE INJECTION, for intravenous use Initial U.S. Approval: 2014 | Baxter Healthcare Corporation |
| 0338-9647 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION . VASOPRESSIN IN SODIUM CHLORIDE INJECTION, for intravenous use Initial U.S. Approval: 2014 | Baxter Healthcare Corporation |
| 0338-9647-12 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION . VASOPRESSIN IN SODIUM CHLORIDE INJECTION, for intravenous use Initial U.S. Approval: 2014 | Baxter Healthcare Corporation |
| 0517-1020 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 0517-1020 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | American Regent, Inc. |
| 0517-1020-01 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | American Regent, Inc. |
| 0517-1020-25 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | American Regent, Inc. |
| 0517-1030 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 0517-1030 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | American Regent, Inc. |
| 0517-1030-01 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | American Regent, Inc. |
| 0548-9701 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection for intravenous use Initial U.S. Approval: 2014 | Amphastar Pharmaceuticals, Inc. |
| 0548-9701-00 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection for intravenous use Initial U.S. Approval: 2014 | Amphastar Pharmaceuticals, Inc. |
| 25021-474 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Sagent Pharmaceuticals |
| 25021-474-01 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Sagent Pharmaceuticals |
| 42023-164 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-164 | VASOSTRICT(TM) (VASOPRESSIN INJECTION, USP) 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 42023-164 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC | Endo USA, Inc. |
| 42023-164 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 42023-164 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Medical Purchasin Solutions, LLC | Medical Purchasing Solutions, LLC |
| 42023-164-01 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-164-10 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-164-25 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-164-83 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC | Endo USA, Inc. |
| 42023-190 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-190-01 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-219 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-219-01 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-219-10 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-220 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-220-01 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-220-10 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-237 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-237-01 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-237-10 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-268 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-268-01 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 42023-268-10 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | Par Health USA, LLC |
| 43598-085 | VASOPRESSIN INJECTION, USP 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 43598-914 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Dr. Reddy's Laboratories, Inc. | Dr. Reddy's Laboratories Limited-FTO-9 |
| 43598-914 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 43598-914-06 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Dr. Reddy's Laboratories, Inc. | Dr. Reddy's Laboratories Limited-FTO-9 |
| 43598-914-11 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Dr. Reddy's Laboratories, Inc. | Dr. Reddy's Laboratories Limited-FTO-9 |
| 43598-914-25 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Dr. Reddy's Laboratories, Inc. | Dr. Reddy's Laboratories Limited-FTO-9 |
| 51662-1314 | VASOSTRICT(TM) (VASOPRESSIN INJECTION, USP) 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1314-1 | VASOSTRICT(TM) (VASOPRESSIN INJECTION, USP) 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1314-2 | VASOSTRICT(TM) (VASOPRESSIN INJECTION, USP) 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1607 | VASOPRESSIN INJECTION, USP 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1607-1 | VASOPRESSIN INJECTION, USP 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1607-2 | VASOPRESSIN INJECTION, USP 20 UNITS PER mL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1623 | VASOPRESSIN INJECTION USP 20 UNITS PER mL 1mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1623-1 | VASOPRESSIN INJECTION USP 20 UNITS PER mL 1mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1623-2 | VASOPRESSIN INJECTION USP 20 UNITS PER mL 1mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1682 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1682-1 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1682-2 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1688 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1688-1 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1688-2 | HF Acquisition Co LLC, DBA HealthFirst DailyMed label | HF Acquisition Co LLC, DBA HealthFirst |
| 52584-302 | VASOPRESSIN INJECTION, USP (SYNTHETIC) | Feneral Injectables & Vaccines, Inc |
| 52584-302-01 | VASOPRESSIN INJECTION, USP (SYNTHETIC) | Feneral Injectables & Vaccines, Inc |
| 55150-370 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Eugia US LLC | Eugia Pharma Specialities Limited |
| 55150-370 | VASOPRESSIN INJECTION USP 20 UNITS PER mL 1mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 55150-370 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | ProPharma Distribution |
| 55150-370 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 55150-370 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Eugia US LLC | Eugia Pharma Specialities Limited |
| 55150-370-01 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Eugia US LLC | Eugia Pharma Specialities Limited |
| 55150-370-24 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Eugia US LLC | Eugia Pharma Specialities Limited |
| 55150-370-25 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Eugia US LLC | Eugia Pharma Specialities Limited |
| 63323-302 | VASOPRESSIN INJECTION, USP (SYNTHETIC) | Feneral Injectables & Vaccines, Inc |
| 63323-930 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC |
| 63323-930-00 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC |
| 63323-930-01 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC |
| 65219-039 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC |
| 65219-039-00 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC |
| 65219-039-01 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC |
| 68083-520 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use. VASOPRESSIN in dextrose injection for intravenous use Initial U.S. Approval: 2014 | Gland Pharma Limited |
| 68083-520-10 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use. VASOPRESSIN in dextrose injection for intravenous use Initial U.S. Approval: 2014 | Gland Pharma Limited |
| 68083-520-25 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use. VASOPRESSIN in dextrose injection for intravenous use Initial U.S. Approval: 2014 | Gland Pharma Limited |
| 68083-663 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use. VASOPRESSIN in dextrose injection for intravenous use Initial U.S. Approval: 2014 | Gland Pharma Limited |
| 68083-663-10 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use. VASOPRESSIN in dextrose injection for intravenous use Initial U.S. Approval: 2014 | Gland Pharma Limited |
| 70121-1642 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION . VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | Steril-Gene Life Sciences Private Limited |
| 70121-1642-1 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION . VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | Steril-Gene Life Sciences Private Limited |
| 70121-1642-2 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION . VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | Steril-Gene Life Sciences Private Limited |
| 70121-1642-5 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION . VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | Steril-Gene Life Sciences Private Limited |
| 70121-1642-7 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION . VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | Steril-Gene Life Sciences Private Limited |
| 71872-7014 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Medical Purchasin Solutions, LLC | Medical Purchasing Solutions, LLC |
| 71872-7014-1 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Medical Purchasin Solutions, LLC | Medical Purchasing Solutions, LLC |
| 71872-7264 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 71872-7264-1 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 71872-7306 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 71872-7306-1 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 71872-7334 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 71872-7334-1 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Medical Purchasing Solutions, LLC |
| 72572-860 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Civica, Inc. | American Regent, Inc. |
| 72572-860-25 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Civica, Inc. | American Regent, Inc. |
| 81298-8552 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC |
| 81298-8552-1 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC |
| 81298-8552-3 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC |
| 81298-8554 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC |
| 81298-8554-1 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC |
| 81298-8554-3 | These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC |
| 83818-006 | 83818-006 | Shenzhen Xinxin Yunhai Technology Co., Ltd. |
| 83818-006-01 | 83818-006 | Shenzhen Xinxin Yunhai Technology Co., Ltd. |
| 83818-010 | 83818-010 | Shenzhen Xinxin Yunhai Technology Co., Ltd. |
| 83818-010-01 | 83818-010 | Shenzhen Xinxin Yunhai Technology Co., Ltd. |
| 84549-370 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | ProPharma Distribution |
| 84549-370-25 | These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | ProPharma Distribution |